Related Experiment Video
Updated: Jun 1, 2025

10:46
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
13.3K
Repeat procedures after pulsed field ablation for atrial fibrillation: MANIFEST-REDO study
Daniel Scherr1, Mohit K Turagam2, Philippe Maury3,4
1Division of Cardiology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
Summary
Repeat pulsed field ablation (PFA) for atrial fibrillation (AF) shows common pulmonary vein reconnections but is safe and effective. Patients achieved 65% freedom from arrhythmia after repeat procedures, indicating a viable treatment option.
Area of Science:
- Electrophysiology
- Cardiovascular Medicine
- Medical Technology
Background:
- Initial pulsed field ablation (PFA) studies for atrial fibrillation (AF) reported high pulmonary vein isolation (PVI) durability.
- Limited data exists on repeat ablation outcomes after index PFA, especially regarding electrophysiological findings.
Purpose of the Study:
- To investigate outcomes of repeat ablation procedures in patients experiencing recurrence after initial PFA for AF.
- To assess pulmonary vein (PV) reconnection rates and clinical effectiveness following repeat PFA.
Main Methods:
- The MANIFEST-REDO study included 427 patients undergoing repeat ablation for AF/atrial tachycardia (AT) after first-ever PVI with a PFA catheter.
- PV reconnection rates and clinical success (freedom from AF/AT) were evaluated after a median follow-up of 284 days.
Main Results:
- Pulmonary vein reconnections were observed in 28-33% of PVs during repeat procedures.
- The overall success rate for freedom from AF/AT was 65%, with variations based on initial diagnosis (paroxysmal AF, persistent AF, AT).
- Repeat PFA procedures demonstrated a 2.8% complication rate.
Conclusions:
- Pulmonary vein reconnections are frequent in repeat ablation procedures following index PFA for AF.
- Repeat PFA procedures are safe and offer an acceptable success rate for managing recurrent AF/AT.

